Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12207935rdf:typepubmed:Citationlld:pubmed
pubmed-article:12207935lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:12207935lifeskim:mentionsumls-concept:C0162670lld:lifeskim
pubmed-article:12207935lifeskim:mentionsumls-concept:C0026882lld:lifeskim
pubmed-article:12207935lifeskim:mentionsumls-concept:C0012929lld:lifeskim
pubmed-article:12207935lifeskim:mentionsumls-concept:C0035723lld:lifeskim
pubmed-article:12207935lifeskim:mentionsumls-concept:C0205422lld:lifeskim
pubmed-article:12207935lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:12207935lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:12207935pubmed:issue7-8lld:pubmed
pubmed-article:12207935pubmed:dateCreated2002-9-4lld:pubmed
pubmed-article:12207935pubmed:abstractTextWe describe a novel mutation in the mitochondrial tRNA(Ile) gene, an A to G transition at nucleotide position 4267, in a 37-year-old woman with myopathy, ataxia and sensorineural hearing loss. The A4267G mutation was heteroplasmic in several of the proband's tissues and single fibre analysis revealed significantly higher levels of mutated mitochondrial DNA in cytochrome c oxidase-deficient fibres than cytochrome c oxidase-positive fibres. It is predicted to disrupt a highly conserved base pair within the aminoacyl acceptor stem of the tRNA causing functional impairment, and as such fulfils all the accepted criteria for pathogenicity. Moreover, we were unable to detect the A4267G mutation in lymphocytes, buccal epithelia and hair of the patient's mother and two siblings, implying that the A4267G transition represents a sporadic, germline mutation.lld:pubmed
pubmed-article:12207935pubmed:languageenglld:pubmed
pubmed-article:12207935pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12207935pubmed:citationSubsetIMlld:pubmed
pubmed-article:12207935pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12207935pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12207935pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12207935pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12207935pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12207935pubmed:statusMEDLINElld:pubmed
pubmed-article:12207935pubmed:monthOctlld:pubmed
pubmed-article:12207935pubmed:issn0960-8966lld:pubmed
pubmed-article:12207935pubmed:authorpubmed-author:McFarlandRobe...lld:pubmed
pubmed-article:12207935pubmed:authorpubmed-author:TaylorRobert...lld:pubmed
pubmed-article:12207935pubmed:authorpubmed-author:TurnbullDougl...lld:pubmed
pubmed-article:12207935pubmed:authorpubmed-author:MaddisonPaulPlld:pubmed
pubmed-article:12207935pubmed:authorpubmed-author:SchaeferAndre...lld:pubmed
pubmed-article:12207935pubmed:issnTypePrintlld:pubmed
pubmed-article:12207935pubmed:volume12lld:pubmed
pubmed-article:12207935pubmed:ownerNLMlld:pubmed
pubmed-article:12207935pubmed:authorsCompleteYlld:pubmed
pubmed-article:12207935pubmed:pagination659-664lld:pubmed
pubmed-article:12207935pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12207935pubmed:meshHeadingpubmed-meshheading:12207935...lld:pubmed
pubmed-article:12207935pubmed:meshHeadingpubmed-meshheading:12207935...lld:pubmed
pubmed-article:12207935pubmed:meshHeadingpubmed-meshheading:12207935...lld:pubmed
pubmed-article:12207935pubmed:meshHeadingpubmed-meshheading:12207935...lld:pubmed
pubmed-article:12207935pubmed:meshHeadingpubmed-meshheading:12207935...lld:pubmed
pubmed-article:12207935pubmed:meshHeadingpubmed-meshheading:12207935...lld:pubmed
pubmed-article:12207935pubmed:meshHeadingpubmed-meshheading:12207935...lld:pubmed
pubmed-article:12207935pubmed:meshHeadingpubmed-meshheading:12207935...lld:pubmed
pubmed-article:12207935pubmed:meshHeadingpubmed-meshheading:12207935...lld:pubmed
pubmed-article:12207935pubmed:meshHeadingpubmed-meshheading:12207935...lld:pubmed
pubmed-article:12207935pubmed:meshHeadingpubmed-meshheading:12207935...lld:pubmed
pubmed-article:12207935pubmed:meshHeadingpubmed-meshheading:12207935...lld:pubmed
pubmed-article:12207935pubmed:meshHeadingpubmed-meshheading:12207935...lld:pubmed
pubmed-article:12207935pubmed:meshHeadingpubmed-meshheading:12207935...lld:pubmed
pubmed-article:12207935pubmed:year2002lld:pubmed
pubmed-article:12207935pubmed:articleTitleA novel mitochondrial DNA tRNA(Ile) (A4267G) mutation in a sporadic patient with mitochondrial myopathy.lld:pubmed
pubmed-article:12207935pubmed:affiliationDepartment of Neurology, The Medical School, University of Newcastle upon Tyne, Framlington Place, NE2 4HH, Newcastle upon Tyne, UK. r.w.taylor@newcastle.ac.uklld:pubmed
pubmed-article:12207935pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12207935pubmed:publicationTypeCase Reportslld:pubmed
pubmed-article:12207935pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:4567entrezgene:pubmedpubmed-article:12207935lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:12207935lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12207935lld:pubmed